Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7797]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Bortezomib can improve outcomes in newly diagnosed mantle-cell lymphoma
Bortezomib can improve outcomes in newly diagnosed mantle-cell lymphoma
Cancer immunotherapeutics in drug discovery
Cancer immunotherapeutics in drug discovery
Medical nanoparticles transport drugs for local treatment of lung cancer
Medical nanoparticles transport drugs for local treatment of lung cancer
New indication for bevacizumab in cervical cancer
New indication for bevacizumab in cervical cancer
Carfilzomib outperforms bortezomib in patients with relapsed multiple myeloma
Carfilzomib outperforms bortezomib in patients with relapsed multiple myeloma
New breast cancer test links immune ‘hotspots’ to better survival
New breast cancer test links immune ‘hotspots’ to better survival
Pancreatic cancer has four distinct types
Pancreatic cancer has four distinct types
‘Patchwork’ ovarian cancer more deadly
‘Patchwork’ ovarian cancer more deadly
FDA approves panobinostat for multiple myeloma
FDA approves panobinostat for multiple myeloma
ASCO GU: Androgen receptor abnormality may not be associated with primary resistance to taxane chemotherapy
ASCO GU: Androgen receptor abnormality may not be associated with primary resistance to taxane chemotherapy

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation